This study shows that liquid biopsy—blood-based tumor DNA testing—reveals widespread treatment-resistance mutations across 12,827 patients with metastatic

YouTube video by Yale Cancer Center

This study shows that osimertinib reduces brain metastasis risk differences seen between two common EGFR lung cancer mutation subtypes.

This study shows that in pancreatic cancer cells, a cell's baseline state—not which KRAS mutation it carries—drives its molecular behavior.

This study identifies which mutations most strongly drive hepatocellular carcinoma—liver cancer—in Chinese patients by measuring each mutation's selective

This study identifies which mutations most strongly drive hepatocellular carcinoma—liver cancer—in Chinese patients by measuring each mutation's selective

Ropeg showed efficacy and substantial molecular responses with good overall tolerability across a broad ET population.

Published in Leukemia & Lymphoma (Ahead of Print, 2026)

The American Association for Cancer Research (AACR) Trailblazer Cancer Research Grant Program is a historic initiative intended to provide talented investigators with the resources to support innovati...